Literature DB >> 16239551

Murine macrophages kill the vegetative form of Bacillus anthracis.

Tae Jin Kang1, Matthew J Fenton, Matthew A Weiner, Stephen Hibbs, Subhendu Basu, Les Baillie, Alan S Cross.   

Abstract

Anti-protective antigen antibody was reported to enhance macrophage killing of ingested Bacillus anthracis spores, but it was unclear whether the antibody-mediated macrophage killing mechanism was directed against the spore itself or the vegetative form emerging from the ingested and germinating spore. To address this question, we compared the killing of germination-proficient (gp) and germination-deficient (DeltagerH) Sterne 34F2 strain spores by murine peritoneal macrophages. While macrophages similarly ingested both spores, only gp Sterne was killed at 5 h (0.37 log kill). Pretreatment of macrophages with gamma interferon (IFN-gamma) or opsonization with immunoglobulin G (IgG) isolated from a subject immunized with an anthrax vaccine enhanced the killing of Sterne to 0.49 and 0.73 log, respectively, but the combination of IFN-gamma and IgG was no better than either treatment alone. Under no condition was there killing of DeltagerH spores. To examine the ability of the exosporium to protect spores from macrophages, we compared the macrophage-mediated killing of nonsonicated (exosporium+) and sonicated (exosporium-) Sterne 34F2 spores. More sonicated spores than nonsonicated spores were killed at 5 h (0.98 versus 0.37 log kill, respectively). Pretreatment with IFN-gamma increased the sonicated spore killing to 1.39 log. However, the opsonization with IgG was no better than no treatment or pretreatment with IFN-gamma. We conclude that macrophages appear unable to kill the spore form of B. anthracis and that the exosporium may play a role in the protection of spores from macrophages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239551      PMCID: PMC1273904          DOI: 10.1128/IAI.73.11.7495-7501.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  The development of new vaccines against Bacillus anthracis.

Authors:  L Baillie
Journal:  J Appl Microbiol       Date:  2001-10       Impact factor: 3.772

2.  On the histopathology of experimental anthrax in the guinea-pig.

Authors:  J M ROSS
Journal:  Br J Exp Pathol       Date:  1955-06

3.  Factors affecting the germination of spores of Bacillus anthracis.

Authors:  R W Titball; R J Manchee
Journal:  J Appl Bacteriol       Date:  1987-03

Review 4.  Development of novel vaccines against anthrax in man.

Authors:  A V Stepanov; L I Marinin; A P Pomerantsev; N A Staritsin
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

5.  Germination of Bacillus anthracis spores within alveolar macrophages.

Authors:  C Guidi-Rontani; M Weber-Levy; E Labruyère; M Mock
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

6.  Germination of Bacillus cereus spores in response to L-alanine and to inosine: the roles of gerL and gerQ operons.

Authors:  Paul J Barlass; Christopher W Houston; Mark O Clements; Anne Moir
Journal:  Microbiology       Date:  2002-07       Impact factor: 2.777

7.  Identification of proteins in the exosporium of Bacillus anthracis.

Authors:  Caroline Redmond; Leslie W J Baillie; Stephen Hibbs; Arthur J G Moir; Anne Moir
Journal:  Microbiology       Date:  2004-02       Impact factor: 2.777

Review 8.  Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.

Authors:  Taro Fukao
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

9.  Macrophage-mediated germination of Bacillus anthracis endospores requires the gerH operon.

Authors:  Matthew A Weiner; Philip C Hanna
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Identification and characterization of the gerH operon of Bacillus anthracis endospores: a differential role for purine nucleosides in germination.

Authors:  Matthew A Weiner; Timothy D Read; Philip C Hanna
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

View more
  55 in total

1.  Morphogenesis of the Bacillus anthracis spore.

Authors:  Rebecca Giorno; Joel Bozue; Christopher Cote; Theresa Wenzel; Krishna-Sulayman Moody; Michael Mallozzi; Matthew Ryan; Rong Wang; Ryszard Zielke; Janine R Maddock; Arthur Friedlander; Susan Welkos; Adam Driks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

2.  Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis.

Authors:  J Bozue; C K Cote; K L Moody; S L Welkos
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

3.  An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity.

Authors:  Xiao-Ling Li; Heather J Ezelle; Tae-Jin Kang; Lei Zhang; Kari Ann Shirey; Janette Harro; Jeffrey D Hasday; Saroj K Mohapatra; Oswald R Crasta; Stefanie N Vogel; Alan S Cross; Bret A Hassel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

4.  What is the relevance of lung epithelial cells during the dissemination of spores in inhalational anthrax?

Authors:  Jean-Nicolas Tournier; Aurélie Cleret; Anne Quesnel-Hellmann
Journal:  Infect Immun       Date:  2009-01       Impact factor: 3.441

5.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  The spore-specific alanine racemase of Bacillus anthracis and its role in suppressing germination during spore development.

Authors:  Olga N Chesnokova; Sylvia A McPherson; Christopher T Steichen; Charles L Turnbough
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

7.  Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant.

Authors:  Brandon Feinen; Nikolai Petrovsky; Anita Verma; Tod J Merkel
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

8.  Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Authors:  Angelo Scorpio; Donald J Chabot; William A Day; David K O'brien; Nicholas J Vietri; Yoshifumi Itoh; Mansour Mohamadzadeh; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

9.  Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress.

Authors:  Robert J Cybulski; Patrick Sanz; Farhang Alem; Scott Stibitz; Robert L Bull; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

10.  Myeloid differentiation primary response gene 88 is required for the resolution of otitis media.

Authors:  Michelle Hernandez; Anke Leichtle; Kwang Pak; Joerg Ebmeyer; Sara Euteneuer; Marygorret Obonyo; Donald G Guiney; Nicholas J Webster; David H Broide; Allen F Ryan; Stephen I Wasserman
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.